CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-13 Cr | ₹99 Cr | ₹66 Cr | ₹154 Cr |
What is the latest Net Current Assets ratio of CORONA REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹154 Cr |
How is Net Current Assets of CORONA REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹99 Cr | 51.06 | |
| Mar2024 | ₹66 Cr | -57.35 | |
| Mar2023 | ₹154 Cr | - | |
Compare Net Current Assets of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,163.2 Cr | 6.6% | 1.9% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 6.6% |
1.9% |
|
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses